Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
-
FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
-
The Next Generation of the GLP-1 Revolution Is Already Underway
-
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
-
Astrotech Corporation Receives ECAC/EU G1 Certification of Trace Detection in Aviation Security
-
LM Funding America Announces April 2026 Production and Operational Update
-
Duos Technologies Group Sets First Quarter 2026 Earnings Call for Monday, May 18, 2026 at 8:30 AM ET
-
Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology
-
Aeries Technology Partners with Two Circles to Launch New Hyderabad Office
-
SoundThinking Honors Law Enforcement During National Police Week 2026
-
Snail, Inc. Sets First Quarter 2026 Conference Call for Wednesday, May 13, 2026 at 4:30 p.m. ET
-
Axe Compute to Host Q1 2026 Financial Results Conference Call
-
VisionWave Holdings, Inc. to Host Exclusive Investor Events at BiCE Ristorante and at Mar-a-Lago Beach Club in Palm Beach, Florida
-
Announcement of Tender Offer for Any and All 2029 Notes by Movida Europe S.A.
-
Share buy-back program
-
Verizon announces tender offers and consent solicitations for 20 series of Verizon and certain of its subsidiaries’ notes
-
Verizon announces private exchange offers and consent solicitations for 11 series of notes open to certain investors
-
Humanitarian organization CARE marks 80th anniversary of the original CARE PACKAGE®
-
Crypfine Upgrades Proprietary Matching Engine to Fortify Platform Stability in Extreme Market Conditions
-
Dynabook Canada expands AMD-powered offerings with new Portégé® X45W 14-inch 2-in-1 convertible laptop
-
VOYAH Showcases Systemic Innovation and Global Expansion at Beijing Auto Show
-
CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial
-
Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
Jiuzi Holdings, Inc. Announces $210,000 Realized Gains from DCIP Investment and Approves $100,000 Share Repurchase Program, Validating Sustainable Digital Asset Investment Framework
-
Turbo Energy Expands AI-Driven Energy Platform in Chile To Capture Growing Distributed Energy Opportunity
-
CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial
-
Navigator Gas Announces 2026 Annual Meeting
-
Par Pacific Announces Private Placement of $500 Million of Senior Notes
-
Safe Pro’s Edge AI Battlefield Threat Detection Selected by U.S. Army for Upcoming Force-on-Force Combat Exercise
-
Fervo Energy Announces Upsized Proposed Initial Public Offering
-
Sharplink Reports First Quarter 2026 Financial and Operating Results; Now Holds 872,984 ETH in Treasury
-
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
-
CalEthos, Inc. and its subsidiary, TerraVolt Infrastructure, Inc., sign a Natural Gas Supply Agreement for TerraVolt's planned AI Data Center Infrastructure Development
-
Form 8.5 (EPT/RI)- Advanced Medical Solutions Group plc
-
Kalmar Corporation: Share repurchase during week 19
-
Sanoma Corporation, Managers’ Transactions
-
CPTx appoints Edward Rebar as Chief Scientific Officer
-
Sinclair Inc. To Appear at Upcoming Investor Conferences
-
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings
-
Novin AgriTech receives USDA grant to develop novel traits for wheat, accelerate trait integration
-
Aspen Group, Inc. Amends and Extends Debt Agreement
-
TRIO PETROLEUM CORP ANNOUNCES STRATEGIC EXPANSION INITIATIVE FOLLOWING SUCCESSFUL CAPITAL RAISE AND ENCOURAGES STOCKHOLDER SUPPORT AT MAY 21ST ANNUAL MEETING
-
Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
-
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
-
Aditum Lawyers Expands Into Melbourne, Strengthening National Commercial Litigation Capability
-
Uniti Group Inc. Reports First Quarter 2026 Results
-
First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)
-
Tech Consultant Hylaine Presents at the Digital Insurance Summit on Building and Unifying Data, and Scaling Insurance Operations in the Cloud

